UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophy

Neuromuscular disorders : NMD, 2012-12, Vol.22 (12), p.1035-1039

2012

Volltextzugriff (PDF)

Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up

Journal of bone and joint surgery. American volume, 2013-06, Vol.95 (12), p.1057-1061

2013

Volltextzugriff (PDF)

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

Nature communications, 2017-01, Vol.8 (1), p.14143-14143, Article 14143

2017

Volltextzugriff (PDF)

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchenne’s muscular dystrophy

Archives of physical medicine and rehabilitation, 2005-02, Vol.86 (2), p.284-288

2005

Volltextzugriff (PDF)

Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy

Journal of bone and joint surgery. American volume, 2004-03, Vol.86 (3), p.519-524

2004

Volltextzugriff (PDF)

Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy

The American journal of cardiology, 2003-03, Vol.91 (6), p.769-772

2003

Volltextzugriff (PDF)

Duchenne muscular dystrophy

Pediatrics in review, 2006-03, Vol.27 (3), p.83-88

Biggar, W Douglas

2006

Volltextzugriff (PDF)

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy

Acta myologica, 2012-05, Vol.31 (1), p.16-20

2012

Volltextzugriff (PDF)

The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures

Muscle & nerve, 2013-07, Vol.48 (1), p.55-67

2013

Volltextzugriff (PDF)

Adolescents with physical disabilities: Some psychosocial aspects of health

Journal of adolescent health, 1996-08, Vol.19 (2), p.157-164

1996

Volltextzugriff (PDF)

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

Muscle & nerve, 2013-07, Vol.48 (1), p.32-54

2013

Volltextzugriff (PDF)

Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy

American journal of human genetics, 2016-11, Vol.99 (5), p.1163-1171

2016

Volltextzugriff (PDF)

Age-related health risk behaviors of adolescents with physical disabilities

International journal of public health, 2004-01, Vol.49 (2), p.132-141

2004

Volltextzugriff (PDF)

Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy

Value in health, 2021-10, Vol.24 (10), p.1490-1498

2021

Volltextzugriff (PDF)

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

Journal of pharmacokinetics and pharmacodynamics, 2019-10, Vol.46 (5), p.441-455

2019

Volltextzugriff (PDF)

Validation of the Actiheart activity monitor for measurement of activity energy expenditure in children and adolescents with chronic disease

European journal of clinical nutrition, 2010-12, Vol.64 (12), p.1494-1500

2010

Volltextzugriff (PDF)

Deflazacort treatment of Duchenne muscular dystrophy

The Journal of pediatrics, 2001-01, Vol.138 (1), p.45-50

2001

Volltextzugriff (PDF)

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning

Critical care medicine, 1986-06, Vol.14 (6), p.529-534

1986

Volltextzugriff (PDF)

Duchenne muscular dystrophy: current knowledge, treatment, and future prospects

Clinical orthopaedics and related research, 2002-08 (401), p.88-106

2002

Volltextzugriff (PDF)

Enhancement of Human Neutrophil Bactericidal Activity by Chemotactic Factors

Infection and Immunity, 1979-05, Vol.24 (2), p.295-301

1979

Volltextzugriff (PDF)

Malakoplakia: evidence for an acquired disease secondary to immunosuppression

Transplantation, 1981-02, Vol.31 (2), p.109-112

1981

Volltextzugriff (PDF)

Congenital asplenia: immunologic assessment and a clinical review of eight surviving patients

Pediatrics (Evanston), 1981-04, Vol.67 (4), p.548-551

1981

Volltextzugriff (PDF)

Clinical features and abnormal neutrophil function in disseminated staphylococcal disease

Pediatric infectious disease, 1985-03, Vol.4 (2), p.137-141

1985

Volltextzugriff (PDF)

The morbidity and mortality of splenectomy in childhood

Annals of surgery, 1977-03, Vol.185 (3), p.307-310

1977

Volltextzugriff (PDF)

Chronic granulomatous disease of childhood: a changing pattern?

Journal of clinical immunology, 1983-07, Vol.3 (3), p.287-291

1983

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Male
(35)
Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Child
(27)
Adolescent
(18)
Female
(13)
Child, Preschool
(12)
Adult
(11)
Biological And Medical Sciences
(11)
Pediatrics
(11)
Medical Sciences
(10)
Muscular Dystrophy, Duchenne - Drug Therapy
(10)
Immunology
(8)
Immunity, Cellular
(7)
Blood Bactericidal Activity
(6)
Infant
(6)
Muscular Dystrophy
(6)
Muscular Dystrophy, Duchenne - Physiopathology
(6)
Neurology
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fat Embolism Syndrome following minor trauma in Duchenne muscular dystrophy

Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

Alendronate in the treatment of low bone mass in steroid-treated boys with Duchenne’s muscular dystrophy

Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy

Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy

Duchenne muscular dystrophy

The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy

Adolescents with physical disabilities: Some psychosocial aspects of health

The cooperative international neuromuscular research group duchenne natural history study-a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used

Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy

Age-related health risk behaviors of adolescents with physical disabilities

Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy

Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy

Validation of the Actiheart activity monitor for measurement of activity energy expenditure in children and adolescents with chronic disease

Deflazacort treatment of Duchenne muscular dystrophy

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning

Duchenne muscular dystrophy: current knowledge, treatment, and future prospects

Enhancement of Human Neutrophil Bactericidal Activity by Chemotactic Factors

Malakoplakia: evidence for an acquired disease secondary to immunosuppression

Congenital asplenia: immunologic assessment and a clinical review of eight surviving patients

Clinical features and abnormal neutrophil function in disseminated staphylococcal disease

The morbidity and mortality of splenectomy in childhood

Chronic granulomatous disease of childhood: a changing pattern?

Aktive Filter

Suchergebnisse filtern